Abstract
The cover picture shows a label-free screening technique to characterize target–ligand interactions. In the foreground, a triple quadrupole mass spectrometer positioned in a flowering meadow illustrates the environmentally friendly opportunity to realize binding assays based on mass spectrometric quantification of a nonlabeled marker compound for a desired target. By peeling back the illustration of this concept—referred to as MS binding assays—the cover picture visualizes the implementation of this approach to the serotonin transporter (SERT). The study describes the efforts to address binding of nonlabeled fluoxetine enantiomers to SERT, as well as the promising results generated by the application of this MS binding assay strategy. For more details, see the Full Paper by Klaus T. Wanner et al. on p. 1900 ff.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
